{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:47:42Z","timestamp":1790203662652,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clon.2023.06.012","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T11:27:18Z","timestamp":1687001238000},"page":"524-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Organ and Function Preservation in Gastrointestinal Malignancies"],"prefix":"10.1016","volume":"35","author":[{"given":"R.","family":"Sur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.W.","family":"Than","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Taggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sripadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sun Myint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2023.06.012_bib1","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clon.2019.03.045","article-title":"Brachytherapy in the palliation of oesophageal cancer: effective but impractical?","volume":"31","author":"Sinha","year":"2019","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brachy.2019.09.005","article-title":"The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: an AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival","volume":"19","author":"Lancellotta","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clon.2023.06.012_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2016.12.034","article-title":"Brachytherapy for the palliation of dysphagia owing to esophageal cancer: a systematic review and meta-analysis of prospective studies","volume":"122","author":"Fuccio","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.brachy.2020.11.010","article-title":"Review of brachytherapy complications \u2013 upper gastrointestinal tract","volume":"20","author":"Folkert","year":"2021","journal-title":"Brachytherapy"},{"issue":"Suppl","key":"10.1016\/j.clon.2023.06.012_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-8140(94)91191-6","article-title":"Single fraction intraluminal high dose rate radiotherapy for palliation of dysphagia in advanced esophageal cancer","volume":"31","author":"Kulhavy","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib6","first-page":"235","article-title":"Optimization of single fraction high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer: a preliminary report","volume":"11","author":"Kulhavy","year":"1995","journal-title":"Endocuriether\/Hypertherm Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0360-3016(97)00710-4","article-title":"Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer","volume":"40","author":"Sur","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(02)02702-5","article-title":"Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma \u2013 an International Atomic Energy Agency study","volume":"53","author":"Sur","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0360-3016(91)90267-8","article-title":"High-dose-rate intraluminal brachytherapy (HDRIBT) for esophageal cancer","volume":"21","author":"Hishikawa","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/0167-8140(93)90066-H","article-title":"Esophageal ulceration following high-dose-rate intraluminal brachytherapy for esophageal cancer","volume":"28","author":"Hishikawa","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-8140(87)80214-1","article-title":"Radiotherapy of esophageal carcinoma: role of high-dose-rate intracavitary irradiation","volume":"9","author":"Hishikawa","year":"1987","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1148\/radiology.156.2.4011917","article-title":"Early esophageal carcinoma treated with intracavitary irradiation","volume":"156","author":"Hishikawa","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2023.06.012_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiology.159.3.3704151","article-title":"Esophageal stricture following high-dose-rate intracavitary irradiation for esophageal cancer","volume":"159","author":"Hishikawa","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2023.06.012_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1148\/radiology.172.1.2740512","article-title":"Small, superficial esophageal carcinoma treated with high-dose-rate intracavitary irradiation only","volume":"172","author":"Hishikawa","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2023.06.012_bib15","article-title":"Histological findings of esophageal injury induced by intracavitary irradiation","volume":"3","author":"Hishikawa","year":"1985","journal-title":"Radiat Med"},{"key":"10.1016\/j.clon.2023.06.012_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0360-3016(92)90805-R","article-title":"Radiation therapy of esophageal cancer: role of high dose rate brachytherapy","volume":"22","author":"Sur","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.brachy.2022.05.008","article-title":"A\u00a0prospective study of radical external beam radiotherapy versus external beam radiotherapy combined with intraluminal brachytherapy for primary esophageal cancer","volume":"21","author":"Ye","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clon.2023.06.012_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0360-3016(95)91427-T","article-title":"What influences the incidence of complications in esophageal cancer treated with telebrachytherapy? Response to Kumar et\u00a0al., IJROBP 27:1069\u20131072; 1993","volume":"32","author":"Sur","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.radonc.2010.09.001","article-title":"Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency","volume":"97","author":"Rosenblatt","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib20","first-page":"75","article-title":"Palliation of malignant dysphagia from oesophageal cancer. Rotterdam Oesophageal Tumor Study Group","volume":"225","author":"Siersema","year":"1998","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.clon.2023.06.012_bib21","first-page":"202","article-title":"Laser therapy combined with brachytherapy for the palliation of malignant dysphagia","volume":"39","author":"Tan","year":"1998","journal-title":"Singapore Med J"},{"key":"10.1016\/j.clon.2023.06.012_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/gut.50.2.224","article-title":"Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study","volume":"50","author":"Spencer","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.clon.2023.06.012_bib23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single dose brachytherapy versus metal stent placement for palliation of dysphagia from esophageal cancer: multicentre randomized trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2023.06.012_bib24","article-title":"Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?","volume":"90","author":"Sun Myint","year":"2017","journal-title":"B\u00a0J Radiol"},{"issue":"3","key":"10.1016\/j.clon.2023.06.012_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2017.10.022","article-title":"Dose escalation using contact X-ray brachytherapy after external beam radiotherapy as nonsurgical treatment option for rectal cancer: outcomes from a single-center experience","volume":"100","author":"Sun Myint","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2023.06.012_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.clon.2023.06.012_bib27","doi-asserted-by":"crossref","first-page":"822e828","DOI":"10.1016\/j.ijrobp.2013.12.012","article-title":"Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control","volume":"88","author":"Habr-Gama","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2023.06.012_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib29","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3512","article-title":"Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma: the 3-year results of OPERA randomized trial (NCT02505750)","volume":"40","author":"G\u00e9rard","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/codi.14584","article-title":"A\u00a0cohort study of local excision followed by adjuvant therapy incorporating a contact X-ray brachytherapy boost instead of radical resection in 180 patients with rectal cancer","volume":"21","author":"Smith","year":"2018","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clon.2023.06.012_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.radonc.2021.07.021","article-title":"A\u00a0multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision \u2013 preliminary results of the CONTEM1 study","volume":"162","author":"Dhadda","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib32","first-page":"15","article-title":"GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer","volume":"33","author":"Stewart","year":"2022","journal-title":"Clin Transl Clin Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib33","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.3390\/cancers13246333","article-title":"Contact X-ray brachytherapy for older or inoperable rectal cancer patients: short-term oncological and functional follow-up","volume":"13","author":"Custers","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clon.2023.06.012_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clon.2016.09.014","article-title":"Organ preservation using contact radiotherapy for early rectal cancer: outcomes of patients treated at a single centre in the UK","volume":"29","author":"Dhadda","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejca.2016.11.007","article-title":"Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients","volume":"72","author":"Frin","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2023.06.012_bib37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clon.2007.07.018","article-title":"High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal cancer \u2013 Clatterbridge experience","volume":"19","author":"Sun Myint","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2023.06.012_bib38","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ijrobp.2012.02.006","article-title":"Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses","volume":"84","author":"Jakobsen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib39","series-title":"NICE Interventional procedures guidance [IPG531]","article-title":"Preoperative high dose rate brachytherapy for rectal cancer","year":"2015"},{"issue":"4","key":"10.1016\/j.clon.2023.06.012_bib40","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijrobp.2017.01.033","article-title":"Endorectal brachytherapy boost after external beam radiation therapy in elderly or medically inoperable patients with rectal cancer: primary outcomes of the phase 1 HERBERT study","volume":"98","author":"Rijkmans","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.06.012_bib41","first-page":"183","article-title":"High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer","volume":"7","author":"T\u00e9","year":"2015","journal-title":"J\u00a0Contemp Brachyther"},{"key":"10.1016\/j.clon.2023.06.012_bib42","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/cancers14153665","article-title":"MORPHEUS phase II\u2013III study: a pre-planned interim safety analysis and preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers"},{"issue":"Issue 3_suppl","key":"10.1016\/j.clon.2023.06.012_bib43","article-title":"Do non-TME surgery of rectal cancer compromise the chance of cure? Preliminary surgical salvage data from OPERA phase 3 randomised trial","volume":"39","author":"Sun Myint","year":"2021","journal-title":"Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552300225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552300225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:52:30Z","timestamp":1760543550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093665552300225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S093665552300225X"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2023.06.012","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organ and Function Preservation in Gastrointestinal Malignancies","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2023.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}